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ABSTRACT
Gastroesophageal reflux (GER) has been reported as a 
cause of chronic cough (CC) in the United States. It has 
been reported that 5-21% of CC cases are induced by 
GER. In Japan, however, detailed clinical features of 
CC induced by GER have not been described. The 
present study reports on six Japanese patients with 
GER-induced CC. The subjects were all females, with a 
mean age of 72 years. The average body mass index 
was 37kg/m2, indicating obesity. No abnormalities 
were found with regard to concentrations of C-reactive 
protein, peripheral eosinophil counts, serum IgE 
concentrations, serum titers of cold agglutinins or anti-
bodies to Mycoplasma pneumoniae, chest radiograph 
findings, respiratory function tests or blood gas analy-
ses. Bronchial biopsy was performed in three patients 
and showed chronic inflammation characterized by 
lymphocytic infiltration, squamous metaplasia and 
mucosal basement membrane thickening. In the study 
population (Japanese patients), GER-induced CC 
tended to occur in elderly obese women and may be 
attributable to airway inflammation.
Key words: bronchial biopsy, chronic inflammatory 
airway disease, cough, gastroesophageal reflux, 
Japanese.
INTRODUCTION
Chronic cough (CC) is defined as persistent cough of 
unknown etiology with a duration of at least 3 weeks.1,2
Postnasal drip syndrome, cough variant asthma3 and 
gastroesophageal reflux (GER) have been reported as 
major causes of this disorder in the United States.1,2 In 
Japan, however, few cases of CC induced by GER have 
been reported.4 
 Body mass index (BMI) and gastric acid pH, which are 
closely related to the risk of GER,5 differ among the 
human races.6,7 Thus, differences in factors associated 
with GER between patients in Japan and those in the 
United States may affect the incidence of GER-induced 
cough. 
 We report on the clinical features of Japanese patients 
with GER-induced CC. In addition, we discuss the etiol-
ogy of CC, based on the results of bronchial biopsies 
performed using fiberoptic bronchoscopy.
METHODS
Patients
Of patients referred to the Medical Department at 
Niigata Prefectural Kakizaki Hospital and diagnosed with 
CC between April 1992 and March 1994, those that met 
the pre- and post-treatment diagnostic criteria of Irwin 
et al.1,2 were entered into the study. 
 The pretreatment criteria were: (i) symptoms of heart-
burn and a sour taste in the mouth; (ii) barium reflux dur-
ing upper gastrointestinal contrast roentgenography; and 
(iii) esophagitis confirmed by esophagoscopic biopsy. 
The post-treatment criteria were recovery from cough 
after the following regimen: (i) an anti-reflux diet of high 
protein and low fat for three meals a day; (ii) avoiding 
eating and drinking 2-3h prior to sleep except for taking 
medications, (iii) elevation of the upper body when lying 
down; and (iv) administration of metoclopramide and/or 
H2 receptor antagonists.
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Informed consent was obtained from each subject
before the start of the study, which was approved by the
institute's committee on human research.
Clinical findings
The following clinical features were ascertained: age, 
sex, smoking history, past allergic history (bronchial 
asthma, atopic dermatitis, allergic rhinitis and allergic 
conjunctivitis), sinus disease history, presence or absence 
of postnasal drip, BMI (kg/m2), time of cough (morning, 
afternoon, evening, bedtime, sleep or all day), duration 
of cough, time between treatment and recovery, levels of 
C-reactive protein (CRP), peripheral eosinophil counts, 
serum IgE concentration, serum titers of cold agglutinins 
and antibodies to Mycoplasma pneumoniae, vital capac-
ity (%VC, %predicted values), forced expiratory volume 
in 1s (FEV1.0%), blood gases (PaO2, A-aDO2), chest roent-
genogram, and esophagoscopic findings, classified 
according to Savary and Miller.8 Serum IgE concentration 
and titers of antibodies to M. pneumoniae were mea-
sured by enzyme immunoassay and complement fixation, 
respectively (Biomedical Laboratories Corp., Tokyo,
Table 1. Clinical characteristics of the study groups
Japan). Respiratory function was determined using a hot-
wire flowmeter (Autospiro AS-7, Minato Corp., Tokyo, 
Japan). The %VC was predicted using the equation of 
Baldwin et al.,9 and FEV1.0% was calculated according to 
the method of Gaensler.10 Blood gases were analyzed as 
follows. After having the patient in a supine position for at 
least 15min, blood was collected from the brachial 
artery into a heparinized container. PaO2 and PaCO2 were 
then measured with an automatic pH blood gas analyzer 
(Ciba Corning 278, Ciba-Corning-Diagnostic Corp., 
Tokyo, Japan). The ideal alveolar oxygen tension was cal-
culated from PaCO2 according to the method of Comroe 
et al.," and used to calculate the alveolar-arterial oxy-
gen tension gradient (A-aDO2). Esophagoscopic findings 
were evaluated by two or more gastroenterologists. In 
addition, patients underwent bronchial biopsy via flexible 
bronchoscopy with specimens taken from the segmental 
bronchi of the upper, middle and lower lobes.
Results are expressed as the mean±standard devia-
tion and range of values.
RESULTS
Forty-three patients were diagnosed with CC during the 
two years. The 43 cases included 22 cases of post-
infectious cough,12, 13 7 of angiotensin-converting enzyme 
(ACE) inhibitor-induced cough,14, 15 7 of bronchodilator-
resistant cough,16, 17 and 1 of cough variant asthma.3 
 Six patients met the diagnostic criteria1, 2 for GER-
induced CC (Tables 1, 2). None of the patients had used 
ACE inhibitors. They were all female patients with a mean
age of 72±6 years (range, 61-80), and did not have a
history of smoking, allergies or sinus disease. No patient
Table 2. Laboratory findings
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Fig. 1 Histologic features of 
bronchial biopsy specimens (case 
3) showing (a) chronic inflamma-
tion with lymphocytic infiltration in 
the submucosa (HE) and (b) 
mucosal basement membrane 
thickening and focal squamous 
metaplasia (HE).
had postnasal drip. The mean BMI was 37±2kg/m2
(range, 35-40). As regards the time of cough, all patients 
indicated that their cough occurred primarily during
sleep. The mean duration of cough was 22±22 weeks
(range, 5-64) and the mean period between treatment
and recovery was 4.3±1.4 weeks (range, 3-6).CRP con-
centrations, peripheral eosinophil counts, serum IgE con-
centrations, and titers of cold agglutinins and antibodies 
to M. pneumoniae were all normal.
 Mean values for %VC (91.1±8.8%), FEV1.0% (78.8±
7.2%), PaO2 (79.6±4,3 torr) and A-aDO2 (18.6±5.2 torr)
were all within normal range. Chest roentgenograms did 
not reveal any abnormalities. 
  Reflux esophagitis, as detected by esophagoscopy, was 
clas ified according to Savory and Miller's criteria;8 three 
p tients had stage I esophagitis, 2 had stage II, and 1 
had stage IV 
  Bronchial biopsy was performed in 3 of the 6 cases 
before treatment. The results are shown in Figs 1, 2 and 
3. All three had lymphocytic infiltration of the bronchial 
mucosal membranes, but no abnormal eosinophilic infil-
tration. Bronchial basement membrane thickening was
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Fig. 2 Light microscopy of a 
bronchial biopsy specimen from 
case 2 showing an increased 
degree of lymphocytic infiltration 
and mucosal basement membrane 
thickening (HE).
Fig. 3 Light microscopy of a 
bronchial biopsy specimen from 
case 4 showing an increased 
degree of lymphocytic infiltration 
and submucosal edema (HE).
observed in two cases. One case showed squamous 
metaplasia. Thus, these three patients were diagnosed 
with chronic airway inflammation accompanied by lym-
phocytic infiltration.
DISCUSSION
In the present study, all six cases of CC induced by GER 
occurred in elderly obese women who had neither an 
allergic history nor postnasal drip. They showed normal
CRP concentrations, peripheral eosinophil counts, serum 
IgE concentrations, titers of cold agglutinins and antibod-
ies to M. pneumoniae, chest roentgenograms, respiratory 
function tests and blood gases. In addition, three patients 
were diagnosed by bronchial biopsy as having chronic 
airway inflammation accompanied by lymphocytic infil-
tration. Irwin et al. reported that 10% of 49 CC cases 
were induced by GER, with a mean age of 67 years 
(range, 55-77).1 They also reported nine patients with 
GER having CC as the only symptom,18 consisting of four
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male and five female patients with a mean age of 52 
years. Our six patients were all female and older (mean 
age of 72 years) than those studied by Irwin et al. It is well 
known that ACE inhibitors induce cough more frequently 
in women than in men.15 Moreover, it has been reported 
that cough is induced more easily in women than in 
men.19 Therefore, a female predominance of GER-
induced CC is compatible with these reports. 
 Bronchial asthma is considered to be a chronic inflam-
matory disease mainly induced by eosinophilic infiltration 
of the airways.20 In the present study, bronchial biopsy 
revealed that GER-induced CC may be due to chronic 
airway inflammation characterized by lymphocytic infil-
tration. Boulet et al. performed bronchial biopsies in 
seven patients with CC induced by GER (all females) as 
well as in five with CC induced by both GER and post-
nasal drip (one male and four females).21 They observed 
the presence of airway inflammation associated with a 
lymphocytic infiltration. Furthermore, in their study, 10 of 
the 11 cases were female with normal values for FVC and 
FEV1.0%. These results agree with the findings reported 
here. 
 With regard to the etiology of GER-induced CC, two 
hypotheses have been proposed. One is microaspiration 
of hydrochloric acid into the lung due to GER.22 The other 
is bronchoconstriction caused by vagal reflexes from the 
esophagus, trachea and bronchi, enhanced by stimula-
tion of esophageal mucosa by hydrochloric acid.23-25 It is 
difficult to draw definitive conclusions regarding the 
mechanism underlying our results. However, based on 
the bronchial biopsy findings, we speculate that repeated 
tracheobronchial microaspiration of refluxed gastric acid 
or vagally mediated reflux may cause chronic inflamma-
tory damage in bronchial mucosa, in most cases accom-
panied by lymphocytic infiltration, resulting in CC. In 
Japan, further study is needed to investigate the mecha-
nism of reflux-induced cough and airway inflammation, 
to establish whether the mechanism is that of microaspi-
ration or vagally mediated reflux.
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